L-Carnitine transports long-chain fatty acids into mitochondria for β-oxidation, improving energy metabolism and protecting mitochondria. It supports stamina, cognition, and metabolic recovery in athletic and clinical contexts.
L-Carnitine
Also known as: Levocarnitine; β-Hydroxy-γ-trimethylaminobutyric acid
Overview
Benefits
- Increases energy via fat metabolism
- Supports brain function and mood
- Improves endurance and recovery
- Reduces liver fat and improves insulin sensitivity
- Protects mitochondria from stress and aging
Consider This Peptide If You Want To
- Address fatigue, brain fog, or poor recovery
- Support metabolic syndrome, insulin resistance, or fatty liver
- Seek mitochondrial support for aging/endurance
Dosage & Administration
Dosage Guidelines
Recommended Dosage
• Amount:500 mg
• Frequency:daily
• Duration:6 weeks
• Rest Period:
• Time of Day:morning
• Ingestion:oral
Best absorbed on an empty stomach. May be paired with carbohydrates to enhance muscular uptake.
Administration Routes:OralIntravenous
Research Findings on Dosage:
Oral Administration
• Commonly Reported Dosage: 500--2,000 mg daily (divided doses)
• Duration: Continuous or in cycles of 6--12 weeks
• Administration Notes: Best absorbed on an empty stomach; may be paired with carbohydrates to enhance muscular uptake
Intravenous Administration (Clinical Use)
• Dosage: 1--3 g/day in metabolic or cardiac care settings
• Notes: Reserved for acute clinical needs (e.g., dialysis, cardiomyopathy)
Mechanism of Action
Mechanism of Action
How this peptide works in the body
Facilitation of Mitochondrial Fatty Acid Transport and Oxidation
L-Carnitine forms esters with long-chain fatty acids via CPT-I on the outer mitochondrial membrane, producing acylcarnitines that are translocated by CACT into the mitochondrial matrix. Once inside, CPT-II regenerates free carnitine and acyl-CoA, allowing β-oxidation and ATP generation. This mechanism is critical for maintaining energy production in muscle, liver, and heart under stress or fasting.
Preservation of Mitochondrial Membrane Potential and Function
Carnitine stabilizes mitochondrial membranes by reducing acyl-CoA accumulation, which can be toxic at high concentrations. It enhances NADH/NAD⁺ turnover and supports mitochondrial respiratory chain efficiency. In oxidative environments, it prevents mitochondrial permeability transition pore (mPTP) opening, reducing apoptotic signaling and preserving mitochondrial integrity.
Regulation of Lipid Metabolism and Ectopic Fat Deposition
By increasing fatty acid oxidation, L-Carnitine reduces intracellular lipid accumulation, especially in the liver and skeletal muscle. It downregulates SREBP-1c and upregulates PPAR-α, shifting cellular metabolism toward lipid catabolism. This helps improve insulin sensitivity and reduce hepatic steatosis.
Reduction of Oxidative Stress and Enhancement of Antioxidant Defense
L-Carnitine increases activity of key antioxidant enzymes (SOD, GPx) and reduces ROS generation via improved mitochondrial efficiency. It scavenges lipid peroxides and protects cardiolipin---a key phospholipid in mitochondrial membranes---from peroxidation. This supports tissues with high oxidative demand, including the brain, heart, and kidneys.
Support of Neurotransmitter Balance and Neuroprotection
In neuronal cells, L-Carnitine (particularly acetyl-L-carnitine) enhances acetylcholine synthesis, increases NGF receptor sensitivity, and supports mitochondrial function in axonal transport. It reduces glutamate excitotoxicity and improves dopamine signaling in the prefrontal cortex, contributing to better cognition and mood regulation.
Consider Stacking With
- CoQ10 (Ubiquinol)
- NAD+ precursors (e.g., NMN)
- Alpha-lipoic acid
- Epitalon
- Thymalin
Side Effects & Cautions
Common Side Effects
- Mild nausea, GI discomfort, fishy body odor at high doses
Cautions
- Use caution with epilepsy or TMA metabolism issues
- Monitor kidney function with long-term high-dose use
Rare Side Effects
- Seizures in predisposed individuals (rare)
- May increase TMAO in some individuals
Research & References
Research Highlights
Calvani et al., 2000: L-Carnitine supplementation improved muscle energy metabolism in elderly individuals with fatigue
Malaguarnera et al., 2007: Found cognitive benefits in patients with mild cognitive impairment receiving acetyl-L-carnitine
Flanagan et al., 2010: Demonstrated reduced liver fat and improved insulin sensitivity in obese individuals
Koeth et al., 2013: Linked high-dose carnitine to increased TMAO levels, highlighting a gut microbiota-mediated risk
References
Calvani M, et al. "Carnitine and physical fatigue in the elderly." Drugs Exp Clin Res. 2000.
Malaguarnera M, et al. "Acetyl-L-carnitine improves cognitive functions in elderly patients." Int J Clin Pharmacol Res. 2007.
Flanagan JL, et al. "Role of carnitine in fatty acid metabolism and hepatic steatosis." Am J Clin Nutr. 2010.
Koeth RA, et al. "Intestinal microbiota metabolism of L-carnitine and cardiovascular risk." Nat Med. 2013.